Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia
Public ClinicalTrials.gov record NCT03373201. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of this study is to investigate tasimelteon vs. placebo on sleep in healthy individuals after a phase advance in jet lag type insomnia.
Study identification
- NCT ID
- NCT03373201
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 320 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 16, 2017 (Actual)
- Primary completion
- Mar 5, 2018 (Actual)
- Completion
- Mar 5, 2018 (Actual)
- Last update posted
- Sep 15, 2023
2017 – 2018
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigational Site | Little Rock | Arkansas | 72211 | — |
| Vanda Investigational Site | Alameda | California | 94501 | — |
| Vanda Investigational Site | San Diego | California | 92103 | — |
| Vanda Investigational Site | Santa Monica | California | 90404 | — |
| Vanda Investigational Site | Oakland Park | Florida | 33334 | — |
| Vanda Investigational Site | Atlanta | Georgia | 30342 | — |
| Vanda Investigational Site | Chevy Chase | Maryland | 20815 | — |
| Vanda Investigational Site | St Louis | Missouri | 63141 | — |
| Vanda Investigational Site | New York | New York | 10019 | — |
| Vanda Investigational Site | Cincinnati | Ohio | 45212 | — |
| Vanda Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| Vanda Investigational Site | Houston | Texas | 77063 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03373201, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 15, 2023 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03373201 live on ClinicalTrials.gov.